ArticleBMC medical genomics2022

Downregulated TICAM1 is a prognostic biomarker and associated with immune tolerance of Wilms tumor patients.

Zhiyi Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.